UBS AM’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

UBS AM’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-179,647	Closed	-$25.2M	–	2619
2020 Q3	$25.2M	Sell	179,647 -66,796	-27%	-$8.14M	0.01%	706
2020 Q2	$18.5M	Buy	246,443 +53,887	+28%	+$2.82M	0.01%	760
2020 Q1	$5.49M	Sell	192,556 -29,918	-13%	-$775K	﹤0.01%	1023
2019 Q4	$5.58M	Buy	222,474 +120,385	+118%	+$2.88M	﹤0.01%	1149
2019 Q3	$1.78M	Buy	+102,089	New	+$3.09M	﹤0.01%	1664

UBS AM's LVGO Position: Q4 2020 in Review

UBS AM sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 179,647 shares — an estimated $25.2M sold.

UBS AM first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $25.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

UBS AM reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
UBS AM sold 179,647 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $25.2M.
UBS AM first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
UBS AM's Livongo Health, Inc. Common Stock position peaked at $25.2M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on UBS AM's 13F filing for Q4 2020, filed 17 Feb 2021.